Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jochen eReiser"'
Autor:
Sandra eMüller-Krebs, Katharina eNissle, Julia eTsobaneli, Martin eZeier, Lars Philipp Kihm, Zoltan eKender, Thomas eFleming, Peter Paul Nawroth, Jochen eReiser, Vedat eSchwenger
Publikováno v:
Frontiers in Medicine, Vol 2 (2015)
Background:In peritoneal dialysis (PD) residual renal function (RRF) fundamentally contributes to improved quality of life and patient survival. High glucose and advanced glycation end-products (AGE) contribute locally to peritoneal and systemically
Externí odkaz:
https://doaj.org/article/263f8d129d6f4a1fa4471353f9a3ef01
Autor:
Anwar eSiddiq, Derek S. Larson, Nima eNaimi, Muhammad eAshraf, Nancy eCuliberk, Helen eLiapis, Changli eWei, Jochen eReiser, Daniel C. Brennan
Publikováno v:
Frontiers in Medicine, Vol 2 (2015)
Background: Recurrent focal segmental glomerular sclerosis (rFSGS) in renal transplant recipients (RTR) is difficult to predict and treat. Early rFSGS is likely from circulating factors and preformed antibodies. Methods: We present the case of a 23-y
Externí odkaz:
https://doaj.org/article/2a21abe9483448908b19f1084b614855
Autor:
Björn eMeijers, Jochen eReiser
Publikováno v:
Frontiers in Medicine, Vol 1 (2015)
Externí odkaz:
https://doaj.org/article/fafc136a1dbe4de7b9307d7370ffca89
Publikováno v:
Frontiers in Medicine, Vol 1 (2014)
Externí odkaz:
https://doaj.org/article/43bfbceceea04ee3beac0712556367b8
Publikováno v:
Frontiers in Endocrinology, Vol 5 (2014)
Diabetes mellitus (DM) is the most common cause of chronic kidney disease (CKD) and end stage renal disease (ESRD). New onset diabetes mellitus after transplant (NODAT) has been described in approximately 30 percent of non-diabetic kidney transplant
Externí odkaz:
https://doaj.org/article/7d6284d7d0474e7dba3108ddb19b1c5f
Autor:
Sandra eMüller-Krebs, Katharina eNissle, Julia eTsobaneli, Martin eZeier, Lars Philipp Kihm, Zoltan eKender, Thomas eFleming, Peter Paul Nawroth, Jochen eReiser, Vedat eSchwenger
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 2 (2015)
Frontiers in Medicine, Vol 2 (2015)
Background: In peritoneal dialysis (PD), residual renal function (RRF) fundamentally contributes to improved quality of life and patient survival. High glucose and advanced glycation end-products (AGE) contribute locally to peritoneal and systemicall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3125f05e4c15c8d1a5645204b0441b1
https://pubmed.ncbi.nlm.nih.gov/25806370
https://pubmed.ncbi.nlm.nih.gov/25806370
Autor:
Björn eMeijers, Jochen eReiser
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 1 (2015)
Frontiers in Medicine, Vol 1 (2015)
Soluble urokinase receptor (suPAR) is proposed as circulating factor in focal and segmental glomerulosclerosis (FSGS) (1). Spinale et al. attempt to validate the role of suPAR in glomerular disease (2). Their mouse overexpression experiments of physi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23e01d14dff694ecd8180b12abdc209d
https://lirias.kuleuven.be/handle/123456789/626114
https://lirias.kuleuven.be/handle/123456789/626114
